These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

121 related articles for article (PubMed ID: 8001232)

  • 1. Transforming growth factor-beta receptors type I, II and III in phenobarbital-promoted rat liver tumors.
    Reisenbichler H; Chari RS; Boyer IJ; Jirtle RL
    Carcinogenesis; 1994 Dec; 15(12):2763-7. PubMed ID: 8001232
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Phenobarbital selectively promotes initiated cells with reduced TGF beta receptor levels.
    Mansbach JM; Mills JJ; Boyer IJ; De Souza AT; Hankins GR; Jirtle RL
    Carcinogenesis; 1996 Jan; 17(1):171-4. PubMed ID: 8565130
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Rapid development of hepatic tumors in transforming growth factor alpha transgenic mice associated with increased cell proliferation in precancerous hepatocellular lesions initiated by N-nitrosodiethylamine and promoted by phenobarbital.
    Tamano S; Merlino GT; Ward JM
    Carcinogenesis; 1994 Sep; 15(9):1791-8. PubMed ID: 7923571
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Regulation of mannose 6-phosphate/insulin-like growth factor-II receptors and transforming growth factor beta during liver tumor promotion with phenobarbital.
    Jirtle RL; Hankins GR; Reisenbichler H; Boyer IJ
    Carcinogenesis; 1994 Aug; 15(8):1473-8. PubMed ID: 8055622
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Presence of a threshold for promoting effects of phenobarbital on diethylnitrosamine-induced hepatic foci in the rat.
    Kitano M; Ichihara T; Matsuda T; Wanibuchi H; Tamano S; Hagiwara A; Imaoka S; Funae Y; Shirai T; Fukushima S
    Carcinogenesis; 1998 Aug; 19(8):1475-80. PubMed ID: 9744545
    [TBL] [Abstract][Full Text] [Related]  

  • 6. In vitro and in vivo response of hepatocytes from hepatic nodules to the mitoinhibitory effects of phenobarbital.
    Manjeshwar S; Laconi E; Sheikh A; Rao PM; Rajalakshmi S; Sarma DS
    Carcinogenesis; 1994 Sep; 15(9):1963-8. PubMed ID: 7923591
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Quantitative relationship between transforming growth factor-alpha and hepatic focal phenotype and progression in female mouse liver.
    Moser GJ; Wolf DC; Goldsworthy TL
    Toxicol Pathol; 1997; 25(3):275-83. PubMed ID: 9210259
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Interstrain differences in susceptibility to liver carcinogenesis initiated by N-nitrosodiethylamine and its promotion by phenobarbital in C57BL/6NCr, C3H/HeNCrMTV- and DBA/2NCr mice.
    Diwan BA; Rice JM; Ohshima M; Ward JM
    Carcinogenesis; 1986 Feb; 7(2):215-20. PubMed ID: 3948311
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Promotion of hepatocarcinogenesis by phenobarbital in c-myc/TGF-alpha transgenic mice.
    Sanders S; Thorgeirsson SS
    Mol Carcinog; 2000 Jul; 28(3):168-73. PubMed ID: 10942533
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Down-regulation of protein and mRNA expression for transforming growth factor-beta (TGF-beta1) type I and type II receptors in human prostate cancer.
    Guo Y; Jacobs SC; Kyprianou N
    Int J Cancer; 1997 May; 71(4):573-9. PubMed ID: 9178810
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Overexpression of glutamine synthetase is associated with beta-catenin-mutations in mouse liver tumors during promotion of hepatocarcinogenesis by phenobarbital.
    Loeppen S; Schneider D; Gaunitz F; Gebhardt R; Kurek R; Buchmann A; Schwarz M
    Cancer Res; 2002 Oct; 62(20):5685-8. PubMed ID: 12384525
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Transforming growth factor-beta receptors and mannose 6-phosphate/insulin-like growth factor-II receptor expression in human hepatocellular carcinoma.
    Sue SR; Chari RS; Kong FM; Mills JJ; Fine RL; Jirtle RL; Meyers WC
    Ann Surg; 1995 Aug; 222(2):171-8. PubMed ID: 7639583
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Regulation of selection of liver nodules initiated with N-nitrosodiethylamine and promoted with nodularin injections in fischer 344 male rats by reciprocal expression of transforming growth factor-beta1 and its receptors.
    Lim IK; Park SC; Song KY; Park TJ; Lee MS; Kim SJ; Hyun BH
    Mol Carcinog; 1999 Oct; 26(2):83-92. PubMed ID: 10506752
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The quantitative analysis and stability of histochemical markers of altered hepatic foci in rat liver following initiation by diethylnitrosamine administration and promotion with phenobarbital.
    Goldsworthy TL; Pitot HC
    Carcinogenesis; 1985 Sep; 6(9):1261-9. PubMed ID: 2863007
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Suppressive effect of enzymatically modified isoquercitrin on phenobarbital-induced liver tumor promotion in rats.
    Morita R; Shimamoto K; Ishii Y; Kuwata K; Ogawa B; Imaoka M; Hayashi SM; Suzuki K; Shibutani M; Mitsumori K
    Arch Toxicol; 2011 Nov; 85(11):1475-84. PubMed ID: 21445586
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Incorporation of bromodeoxyuridine in glutathione S-transferase-positive hepatocytes during rat multistage hepatocarcinogenesis.
    Dragan YP; Hully J; Crow R; Mass M; Pitot HC
    Carcinogenesis; 1994 Sep; 15(9):1939-47. PubMed ID: 7923588
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Liver regeneration and hepatocarcinogenesis in transforming growth factor-alpha-targeted mice.
    Russell WE; Kaufmann WK; Sitaric S; Luetteke NC; Lee DC
    Mol Carcinog; 1996 Mar; 15(3):183-9. PubMed ID: 8597531
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Dose-response relationship of promotion by phenobarbital in rat two-stage hepatocarcinogenesis].
    Onodera H; Matsushima Y; Uneyama C; Shibutani M; Mitsumori K; Maekawa A; Hayashi Y
    Eisei Shikenjo Hokoku; 1991; (109):55-60. PubMed ID: 1364405
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Liver tumor promotion: effect of phenobarbital on EGF and protein kinase C signal transduction and transforming growth factor-beta 1 expression.
    Jirtle RL; Meyer SA
    Dig Dis Sci; 1991 May; 36(5):659-68. PubMed ID: 2022168
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Phenobarbital at low dose exerts hormesis in rat hepatocarcinogenesis by reducing oxidative DNA damage, altering cell proliferation, apoptosis and gene expression.
    Kinoshita A; Wanibuchi H; Morimura K; Wei M; Shen J; Imaoka S; Funae Y; Fukushima S
    Carcinogenesis; 2003 Aug; 24(8):1389-99. PubMed ID: 12807726
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.